Mesenchymal Stem Cells - Interest Group
References (continued):

  • Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells.
    Mol Biol Cell 2002;13:4279–4295.

  • Marinova-Mutafchieva L, Taylor P, Funa K et al. Mesenchymal cells expressing bone
    morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum
    2000;43:2046–2055.

  • Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: Paradoxes of passaging. Exp
    Hematol 2004;32:414–425.

  • Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived
    mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69–80.

  • Galmiche MC, Koteliansky VE, Briere J et al. Stromal cells from human long-term marrow
    cultures are mesenchymal cells that differentiate following a vascular smooth muscle
    differentiation pathway. Blood 1993;82:66–76.

  • Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal
    stem cells. Science 1999;284:143–147.

  • Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow
    mesenchymal progenitor cells. J Cell Physiol 1999;181:67–73.

  • Sordi V, Malosio ML, Marchesi F et al. Bone marrow mesenchymal stem cells express a
    restricted set of functionally active chemokine receptors capable of promoting migration to
    pancreatic islets. Blood 2005;106:419–427.

  • Le Blanc K, Tammik C, Rosendahl K et al. HLA expression and immunologic properties of
    differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890–896.

  • Baddoo M, Hill K, Wilkinson R et al. Characterization of mesenchymal stem cells isolated from
    murine bone marrow by negative selection. J Cell Biochem 2003;89:1235–1249.

  • Jones EA, Kinsey SE, English A et al. Isolation and characterization of bone marrow
    multipotential mesenchymal progenitor cells. Arthritis Rheum 2002;46:3349–3360.

  • Gindraux F, Selmani Z, Obert L et al. Human and rodent bone marrow mesenchymal stem
    cells that express primitive stem cell markers can be directly enriched by using the CD49a
    molecule. Cell Tissue Res 2007;327:471–483.

  • Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated
    from different strains of inbred mice vary in surface epitopes, rates of proliferation, and
    differentiation potential. Blood 2004;103:1662–1668.

  • Gronthos S, Simmons PJ, Graves SE et al. Integrin-mediated interactions between human
    bone marrow stromal precursor cells and the extracellular matrix. Bone 2001;28:174–181.

  • Zvaifler NJ, Marinova-Mutafchieva L, Adams G et al. Mesenchymal precursor cells in the
    blood of normal individuals. Arthritis Res 2000;2:477–488.

  • Frid MG, Brunetti JA, Burke DL et al. Hypoxia-induced pulmonary vascular remodeling
    requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage
    lineage. Am J Pathol 2006;168:659–669.

  • In't Anker PS, Noort WA, Scherjon SA et al. Mesenchymal stem cells in human second-
    trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a
    heterogeneous multilineage differentiation potential. Haematologica 2003;88:845–852.

  • Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in
    hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:321–334.

  • Gotherstrom C, Ringden O, Tammik C et al. Immunologic properties of human fetal
    mesenchymal stem cells. Am J Obstet Gynecol 2004;190:239–245.
Look at uadreams directory